12952 Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Rules and Regulations

contains 10 to 30 grams (g) of bacitracin

MD and approximately 400 g of CTC per

ton varying with body weight and food

consumption to provide 10 milligrams

of CTC per pound of body weight per

day. The feed is indicated for increased

rate of weight gain and improved feed

efficiency due to the activity of

bacitracin, and treatment of bacterial

enteritis caused by Escherichia coli and

Salmonella choleraesuis and bacterial

pneumonia caused by Pasteurella

multocida susceptible to CTC. The

NADA is approved as of September 18,

1996, and the regulations are amended

by revising 21 CFR 558.76(d)(1) and by

adding 21 CFR 558.128(c)(3)(xiv) to

reflect the approval. The basis for

approval is discussed in the freedom of

information summary.

In accordance with the freedom of

information provisions of part 20 (21

CFR part 20) and § 514.11(e)(2)(ii) (21

CFR 514.11(e)(2)(ii)), a summary of

safety and effectiveness data and

information submitted to support

approval of this application may be seen

in the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857, between

9 a.m. and 4 p.m., Monday through

Friday.

Under section 512(c)(2)(ii) of the

Federal Food, Drug, and Cosmetic Act,

this approval does not qualify for

marketing exclusivity because the

application contains no new clinical or

field investigations (other than

bioequivalence or residue studies)

essential to the approval of the

application and conducted or sponsored

by the applicant.

The agency has determined under 21

CFR 25.24(d)(1)(ii) that this action is of

a type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

List of Subjects in 21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21

CFR part 558 is amended as follows:

PART 558—NEW ANIMAL DRUGS FOR

USE IN ANIMAL FEEDS

1. The authority citation for 21 CFR

part 558 continues to read as follows:

Authority: Secs. 512, 701 of the Federal

Food, Drug, and Cosmetic Act (21 U.S.C.

360b, 371).

2. Section 558.76 is amended in the

table in paragraph (d)(1) under entry (iv)

by adding a new item for

Chlortetracycline approximately 400 to

read as follows:

§ 558.76 Bacitracin methylene disalicylate.

* * * * *

(d) * * *

(1) * * *

Bacitracin methylene disalicylate in

grams per ton

Combination in grams per

ton Indications for use Limitations Sponsor

* * * * * * *

(iv) 10 to 30 * * * * * * * * * * * *

Chlortetracycline approximately 400, varying with

body weight and food

consumption to provide

10 milligrams per pound

of body weight per day.

Swine; for increased rate of

weight gain and improved

feed efficiency; for treatment of bacterial enteritis

caused by Escherichia

coli and Salmonella

choleraesuis and bacterial pneumonia caused

by Pasteurella multocida

susceptible to

chlortetracycline.

Feed for not more than 14

days to provide 10 milligrams of chlortetracycline

per pound of body weight

per day; as

chlortetracycline provided

by No. 046573 in

§ 510.600(c) of this chapter.

046573

* * * * * * *

* * * * *

3. Section 558.128 is amended by

adding new paragraph (c)(3)(xiv) to read

as follows:

§ 558.128 Chlortetracycline.

* * * * *

(c) * * *

(3) * * *

(xiv) Bacitracin methylene

disalicylate in accordance with § 558.76.

Dated: February 6, 1997.

Stephen F. Sundlof,

Director, Center for Veterinary Medicine.

[FR Doc. 97–6876 Filed 3–18–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

24 CFR Part 206

[Docket No. FR–2958–F–07]

RIN 2502–AF32

Home Equity Conversion Mortgage

Insurance Demonstration: Additional

Streamlining; Correction

AGENCY: Office of the Assistant

Secretary for Housing-Federal Housing

Commissioner, HUD.

ACTION: Final rule; Correction.

SUMMARY: On September 17, 1996 (61

FR 49030), the Department issued a

final rule to the changes proposed on

May 10, 1996, to the Home Equity

Conversion Mortgage (HECM) Insurance

Demonstration. The final rule had an

effective date of October 17, 1996,

except that the amendment to the

definition of ‘‘principal limit’’ in

§ 206.3, had a delayed effective date of

January 5, 1997. On December 26, 1996

(61 FR 67930), the Department further

delayed the effective date of the

definition of ‘‘principal limit’’ in § 206.3

until May 1, 1997, but inadvertently did

not change the date as it was set forth

within the definition in two places.

Today’s notice corrects the references to

the date contained in the definition of

‘‘principal limit,’’ as it was set forth in

the December 26, 1996 publication to

conform to the intent of the December
Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Rules and Regulations 12953

26, 1996 notice. Today’s notice also

makes two other technical corrections to

conform with the intent of the

September 17, 1996 final rule.

DATES: Effective date of this document:

December 26, 1996.

Effective date for amended definition

of ‘‘principal limit’’ in § 206.3: May 1,

1997.

FOR FURTHER INFORMATION CONTACT:

Mark W. Holman, Acting Director,

Home Mortgage Insurance Division,

Office of Insured Single Family

Housing, Room number 9270,

Department of Housing and Urban

Development, 451 Seventh Street, SW,

Washington, DC 20410, telephone (202)

708–2121; TTY (202) 708–4594. (These

are not toll-free telephone numbers.)

SUPPLEMENTARY INFORMATION: The

September 17, 1996 final rule issued by

the Department delayed the effective

date for the amendment to the definition

of ‘‘principal limit’’ in § 206.3 until

January 5, 1997. The December 26, 1996

document further delayed the effective

date for the definition of ‘‘principal

limit’’ in § 206.3, until May 1, 1997, but

inadvertently neglected to change the

date references within the definition in

two places. The correct date references

of May 1, 1997 are being substituted

through this correction notice. This

notice also corrects the definition of

‘‘principal limit,’’ as it was set forth in

the September 17, 1996 final rule by

changing ‘‘unless’’ in the fifth sentence

to ‘‘if’’ so that the definition clearly

applies the changed method of

calculating principal limit to mortgages

executed on or after May 1, 1997, as was

intended by the September 17, 1996

final rule. In addition, this notice

corrects the sixth sentence of the

definition of ‘‘principal limit,’’ as it was

set forth in the September 17, 1996 final

rule to add the words ‘‘each month’’

after ‘‘increases’’ and the words ‘‘onetwelfth of’’ after ‘‘rate equal to.’’

Accordingly, in FR Doc. 96–23717, on

page 49032, the definition of ‘‘principal

limit’’ in § 206.3, as set forth in the final

rule published on September 17, 1996,

at 61 FR 49030, is corrected to read as

follows:

§ 206.3 Definitions.

* * * * *

Principal limit means the maximum

disbursement that could be received in

any month under a mortgage, assuming

that no other disbursements are made,

taking into account the age of the

youngest mortgagor, the mortgage

interest rate, and the maximum claim

amount. Mortgagors over the age of 95

will be treated as though they are 95 for

purposes of calculating the principal

limit. The principal limit is used to

calculate payments to a mortgagor. It is

calculated for the first month that a

mortgage could be outstanding using

factors provided by the Secretary. It

increases each month thereafter at a rate

equal to one-twelfth of the mortgage

interest rate in effect at that time, plus

one-twelfth of one-half percent per

annum, if the mortgage was executed on

or after May 1, 1997. If the mortgage was

executed before May 1, 1997, the

principal limit increases each month at

a rate equal to one-twelfth of the

expected average mortgage interest rate

plus one-twelfth of one-half percent per

annum. The principal limit may

decrease because of insurance or

condemnation proceeds applied to the

mortgage balance under § 209.209(b) of

this chapter.

* * * * *

Dated: March 13, 1997.

Nicolas P. Retsinas,

Assistant Secretary for Housing-Federal

Housing Commissioner.

[FR Doc. 97–6860 Filed 3–18–97; 8:45 am]

BILLING CODE 4210–27–P

ENVIRONMENTAL PROTECTION

AGENCY

40 CFR Part 180

[OPP–300460; FRL–5594–2]

RIN 2070–AB78

Imidacloprid; Pesticide Tolerances for

Emergency Exemptions

AGENCY: Environmental Protection

Agency (EPA).

ACTION: Final rule.

SUMMARY: This regulation establishes a

time-limited tolerance for combined

residues of the pesticide imidacloprid in

or on the raw agricultural commodity

crop group, cucurbits (Crop Group 9

cucumbers, melons, and squash) in

connection with EPA’s granting of

emergency exemptions under section 18

of the Federal Insecticide, Fungicide,

and Rodenticide Act authorizing use of

imidacloprid on cucurbits in Texas and

California. This regulation establishes

maximum permissible levels for

residues of imidacloprid in these foods.

This tolerance will expire on March 31,

1998.

DATES: This regulation becomes

effective March 19, 1997. The entry in

the table expires on March 31, 1998.

Objections and requests for hearings

must be received by EPA on or before

May 19, 1997.

ADDRESSES: Written objections and

hearing requests, identified by the

docket control number, [OPP–300460],

must be submitted to: Hearing Clerk

(1900), Environmental Protection

Agency, Rm. M3708, 401 M St., SW.,

Washington, DC 20460. Fees

accompanying objections and hearing

requests shall be labeled ‘‘Tolerance

Petition Fees’’ and forwarded to: EPA

Headquarters Accounting Operations

Branch, OPP (Tolerance Fees), P.O. Box

360277M, Pittsburgh, PA 15251. A copy

of any objections and hearing requests

filed with the Hearing Clerk identified

by the docket control number, [OPP–

300460], must also be submitted to:

Public Response and Program Resources

Branch, Field Operations Division

(7506C), Office of Pesticide Programs,

Environmental Protection Agency, 401

M St., SW., Washington, DC 20460. In

person, bring a copy of objections and

hearing requests to Rm. 1132, CM #2,

1921 Jefferson Davis Highway.,

Arlington, VA.

A copy of objections and hearing

requests filed with the Hearing Clerk

may also be submitted electronically by

sending electronic mail (e-mail) to: oppdocket@epamail.epa.gov. Such copies of

objections and hearing requests must be

submitted as an ASCII file avoiding the

use of special characters and any form

of encryption. Copies of objections and

hearing requests will also be accepted

on disks in WordPerfect 5.1 file format

or ASCII file format. All copies of

objections and hearing requests in

electronic form must be identified by

the docket control number [OPP–

300460]. No Confidential Business

Information (CBI) should be submitted

through e-mail. Electronic copies of

objections and hearing requests on this

rule may be filed online at many Federal

Depository Libraries.

FOR FURTHER INFORMATION CONTACT: By

mail: Andrea Beard, Registration

Division (7505W), Office of Pesticide

Programs, Environmental Protection

Agency, 401 M St., SW., Washington,

DC 20460. Office location, telephone

number, and e-mail: Sixth Floor, Crystal

Station #1, 2800 Jefferson Davis

Highway, Arlington, VA 22202. (703)

308–8791, e-mail:

beard.andrea@epamail.epa.gov.

SUPPLEMENTARY INFORMATION: EPA,

pursuant to section 408(e) and (l)(6) of

the Federal Food, Drug, and Cosmetic

Act (FFDCA), 21 U.S.C. 346a(e) and

(l)(6), is establishing tolerances for

residues of the pesticide imidacloprid

(1-[(6-chloro-3-pyridinyl)methyl]-Nnitro-2-imidazolidinimine), in or on

cucurbits, at 0.2 part per million (ppm).

This tolerance will expire and be

revoked automatically without further

action by EPA on March 31, 1998.